Levofloxacina
Levoxacin, Tavanic e altri
Bibliografia - Quali fonti bibliografiche per Levofloxacina?
Tweet
1. Baden L.R. et al., JAMA, 2001, 286 (24), 3115.
2. Bar-Oz B. et al., Eur. J. Obstet. Gynecol. Reprod. Biol., 2009, 143 (2), 75.
3. Bauer L.A. et al., Antimicrob. Agents Chemother., 2005, 49 (4), 1649.
4. Bellon A. et al., Eur. J. Clin. Pharmacol., 2009, 65 (10), 959.
5. Bollettino d’Informazione sui Farmaci, 2009, 1, 24.
6. Bril F. et al., Curr Drug Saf., 2010, 5 (1), 85.
7. Brouwers J.R., Drug Saf., 1992, 7 (4), 268.
8. Cambau E., Gutmann L., Drugs, 1993, 45 Suppl. 3, 15.
9. Canut A. et al., J. Antimicrob. Chemother., 2007, 60 (3), 605.
10. Cheng H. et al., Zhonghua Yi Xue Za Zhi, 2010, 90 (2), 79.
11. Chien S.C. et al., J. Clin. Pharm. Ther., 2002, 27 (1), 7.
12. Coban A.Y. et al., Chemotherapy, 2004, 50 (1), 22.
13. Corrao G. et al., Drug Saf., 2006, 29, 889.
14. De Abate C.A. et al., Respir. Care, 1997, 42, 206.
15. Deng J.Y., Tovar J.M., Ann. Pharmacother., 2006, 40 (9), 1692.
16. Dupont H.L., Drugs, 2006, 66, 303.
17. Durey A. et al., Yonsei Med. J., 2010, 51 (3), 454.
18. Empey P.E. et al., Ann. Pharmacother., 2001, 35 (6), 687.
19. Faruquee C.F. et al., Pak. J. Pharm. Sci., 2010, 23 (2), 143.
20. Federico S. et al., Clin. Pharmacokinet., 2006, 45 (2), 169.
21. File T.M., Antimicrob. Agents Chemother., 1997, 41, 1965.
22. Fish D.N., Chow A.T., Clin. Pharmacokinet., 1997, 32 (2), 101.
23. Fu K.P. et al., Microbiology & Infect. Dis., 1992a, 15, 375.
24. Fuhr U. et al., Antimicrob. Agents Chemother., 1992, 36 (5), 942.
25. Gargallo Viola D. et al., Antimicrobial. Agents Chemother., 1991, 35 (3), 442.
26. Giamarellou H. et al., Am. J. Med., 1989, 87 (5A), 49S.
27. Habib M.P. et al., Infect. Dis. Clin. Pract., 1998, 7, 101.
28. Hsiao S.H. et al., Ann. Pharmacother., 2005, 39 (1), 146.
29. Informazioni sui farmaci, 1998, 5, 117.
30. Informazioni sui farmaci, 2009, 4, 95.
31. Iwamoto K. et al., Drugs, 1993, 45 Suppl. 3, 290.
32. Jones C.B., Fugate S.E., Ann. Pharmacother., 2002, 36 (10), 1554.
33. Kelesidis T. et al., J. Clin. Microbiol., 2010, consultabile on line all’indirizzo: http://www.ncbi.nlm.nih.gov/pubmed/20305011
34. Kim J. et al., Drug Metab. Pharmacokinet., 2009, 24 (2), 167.
35. Lardizabal D.V., Headache, 2009, 49 (2), 300.
36. Larsen H. et al., Int. J. Antimicrob. Agents., 2001, 18 (3), 259.
37. Lee L.J. et al., Antimicrob. Agents Chemother., 1997, 41 (10), 2196.
38. Lewin C.S. et al., J. Pharmacy Pharmacol., 1991, 43, 492.
39. Lewis R.J., Mohr J.F. 3rd., Drug Saf., 2008, 31 (4), 283.
40. Liu H.H. et al., Drug Saf., 2010, 33 (5), 353.
41. McGregor J.C. et al., Ther. Clin. Risk Manag., 2008, 4 (5), 843.
42. Morrissey I. et al., J. Pharmacy Pharmacol., 1992, 44 Suppl., 1057.
43. Murillo O. et al., Antimicrob. Agents Chemother., 2008, 52 (10), 3681.
44. Muzi F. et al., Transplant Proc., 2007, 39, 1673.
45. Nakamura H. et al., Ann. Pharmacother., 2001, 35 (6), 691.
46. Nakashima M. et al., Jap. J. Clin. Pharmacol. Therap., 1992, 23, 515.
47. Nichols R.L. et al., South Med. J., 1997, 90, 1193.
48. Nicodemo A.C. et al., Int. J. Clin. Pract., 1998, 52, 69.
49. Norrby S.R. et al., Scand. J. Infect. Dis., 1998, 30, 397.
50. Oh Y.R. et al., Ann. Pharmacother., 2003, 37 (7-8), 1010.
51. Paglia M. et al., Curr. Med. Res. Opin., 2010, consultabile on line all’indirizzo: http://www.ncbi.nlm.nih.gov/pubmed/20394471
52. Pai M.P. et al., J. Cyst. Fibros., 2006, 5 (3), 153.
53. Papastavros T. et al., C.M.A.J., 2002, 167 (2), 131.
54. Patel P.D. et al., Tex. Heart Inst. J., 2010, 37 (2), 216.
55. Petitjeans F. et al., Eur. J. Clin. Pharmacol., 2003, 59 (10), 779.
56. Richard G.A. et al., Urology, 1998, 52, 51.
57. Saraya A. et al., Eur. J. Pharmacol., 2004, 497 (1), 111.
58. Shakeri-Nejad K., Stahlmann R., Expert. Opin. Pharmacother., 2006, 7 (6), 639.
59. Shi R. et al., Mini Rev. Med. Chem., 2007, 7 (11), 1177.
60. Simkó J. et al., Infection, 2008, 36 (3), 194.
61. Slobodin G. et al., Neurol. Sci., 2009, 30 (2), 159.
62. Stergiopoulou T. et al., J. Antimicrob. Chemother., 2009, 63 (2), 343.
63. Sultana N. et al., Pak. J. Pharm. Sci., 2004, 17 (2), 67.
64. Tanaka M. et al., J. Antimicrob. Ther., 1990, 26, 659.
65. The Medical letter, 2002, 10, 43.
66. The Medical letter, 2008, 18, 71.
67. Tsang K.W. et al., Eur. Respir. J., 1999, 14 (5), 1206.
68. Vadlamudi R.S. et al., South. Med. J., 2007, 100 (7), 720.
69. Wallace A.W. et al., J. Clin. Pharmacol., 2003, 43 (5), 539.
70. Watanabe T. et al., Arzneimittelforschung, 1992, 43 (3A), 374.
71. West M. et al., Clin. Ther., 2003, 25 (2), 485.
72. Wogelius P. et al., Int. J. Antimicrob. Agents., 2005, 26 (4), 323.
73. Yokota T. et al., Chemother., 1992, 40 Suppl. 3, 27.